CVS Health   Report issue

For profit Phase 4
Founded: Woonsocket RI United States (1996)
Status: No NME R&D (1996)

Organization Overview

First Clinical Trial
2022
NCT05514002
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

CVS Health Clinical Trial Services | CVS Health Clinical Trial Services LLC

Active Ingredients

Drugs in Phase 4 Trials (2)

Key: CVS Health (1) Acquired (1)

alpha-1 antitrypsin (Prolastin) (1 trial)

inactivated influenza vaccine (1 trial)

Indications

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2